Phase IIa definition

Phase IIa means a Phase II clinical trial whose primary objective is to explore safety and tolerability (assessed in a descriptive analysis), including pharmacokinetic and pharmacodynamic effects in human patients in a study of at least four (4) weeks duration or longer.
Phase IIa means a Phase II that utilizes the pharmacokinetic and pharmacodynamic information obtained from one or more previously conducted Phase I or other Phase IIa in order to confirm the optimal manner of use of the applicable Product or New Collaboration Compound (dose and dose regimes) and to better determine safety and efficacy.
Phase IIa means a human clinical trial of a Licensed Compound or Licensed Product, the principal purpose of which is a determination of safety and initial efficacy, including proof-of-concept, in the target patient population, which is prospectively designed to generate sufficient data that may permit commencement of further clinical trials, or a similar clinical study prescribed by the Regulatory Authorities, from time to time, pursuant to Applicable Law or otherwise, including the trials referred to in 21 C.F.R. §312.21(b), as amended.

Examples of Phase IIa in a sentence

  • In the ING111521 Phase IIa study (described above), DTG demonstrated low PK variability and a steady- state half/life (t½) of 14 hours.

  • For Phase I, Phase II and Phase IIa studies, the final study data tables will be provided in the form of a Final Study Data Report.

  • Indeed, in a contemporary way, the second phase of these clinical trials (Phase IIa) is generally presented as ‘proof of concept’ studies (Cartwright, 2010; Corr and Williams, 2009; Preskorn, 2014, Yuan et al., 2015).

  • This work includes, but is not limited to, working with the FDA to better understand and refine the next steps in development of the product.On August 13, 2014, the Company announced that the preliminary results of its Phase IIa Clinical Trial, TARDOXALTM for the Treatment of Tardive Dyskinesia (TEND-TD) showed a non-statistically significant improvement in the primary efficacy endpoint in patients treated with TARDOXALTM.

  • Miss G's contact with St Leger Homes is described in more detail in the next section of the report.


More Definitions of Phase IIa

Phase IIa means that part of the Phase II Clinical Trial designed to assess dosing requirements and efficacy of the Licensed Product. For the purposes of this Agreement, “completion of Phase IIA” means that stage of the Phase II Clinical Trial when the efficacy of the Licensed Product as specified in the Development Plan has been observed and properly recorded.
Phase IIa means one or more Phase II trials (at least one of which trials was conducted in a Major Market Country) collectively designed to demonstrate (a) in the case of a Neurological Indication, safety and tolerability in the target population, and (b) in the case of a Psychiatric Indication, clinical proof of concept. [*] CONFIDENTIAL TREATMENT IS REQUESTED
Phase IIa as used herein, shall have the same meaning as such term is used in the SB/HGS License Agreement.
Phase IIa means the construction of one or more buildings on the Phase IIA Property consisting of at least 9,000 gross leasable square feet of commercial space accommodating retail, restaurant, or service tenants.
Phase IIa means a [**] Phase II study of a Licensed Product in patients with a disease target being studied.
Phase IIa means a human clinical trial performed to estimate the biologic or clinical effect of a pharmaceutical product in a target population.
Phase IIa means one or more Phase IIa trials (at least one of which is conducted in a Major Market Country) collectively designed to demonstrate preliminary proof of clinical efficacy using medically recognized surrogate markers or end points.